OXYGEN BIOTHERAPEUTICS, INC. 4
4 · OXYGEN BIOTHERAPEUTICS, INC. · Filed Jul 26, 2013
Insider Transaction Report
Form 4
DiTonno Anthony A
Director
Transactions
- Purchase
Series C 8% Convertible Preferred Stock
2013-07-23+5→ 5 totalExercise: $1.95From: 2013-07-23→ common stock (2,564 underlying) - Purchase
Common Stock Warrants (right to buy)
2013-07-23+2,565→ 2,565 totalExercise: $2.60From: 2013-07-23Exp: 2019-07-23→ common stock (2,565 underlying)
Footnotes (2)
- [F1]The Series C 8% Convertible Preferred Stock has no expiration date.
- [F2]The reported securities are included within 25 Units purchased by the reporting person for $1,000 per Unit. Each Unit consists of (1) a share of Series C 8% Convertible Preferred Stock which is convertible into approximately 512.82 shares of our common stock, and (2) one warrant exercisable for 512.82 shares of common stock at an exercise price of $2.60 per share.